ureteroscopic lithotripsy
Conditions
Interventions
The oxycodone group:At the end of ureteroscopic lithotripsy(Before indwelling double J tube), 0.05mg/kg oxycodone injection was injected intravenously
Control group Sufentanil group:At the end of ureteroscopic lithotripsy(Before indwelling double J tube), 0.1ug/kg sufentanil was injected intravenously
Sponsors
Shenzhen Second People's Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 60 Years
Inclusion criteria
Inclusion criteria: 1. American Society of Anesthesiologists ASA grade I ~ III; 2. Day surgery patients who plan to undergo hard tube lithotripsy for urethral delivery; 3. age 18-60 years old; 4. The subjects voluntarily joined the study and signed the informed consent.
Exclusion criteria
Exclusion criteria: 1, liver and kidney insufficiency; 2. Allergic to the drug to be used; 3. History of chronic pain; 4. A history of long-term use of sedatives and opioids or a history of opioid use within one week; 5. Patients who cannot cooperate; 6. Patients who are not expected to be discharged within 24 hours; 7. Body mass index (BMI) 28 kg/m2; 8. Malignant tumors or autoimmune diseases
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pain VAS score at 4h after operation in two groups; | — |
Secondary
| Measure | Time frame |
|---|---|
| Pain VAS score;Ramsay score;Recovery time;Incidence of adverse reactions;Patient satisfaction;The number and dosage of remedial drugs used; | — |
Countries
China
Contacts
Public ContactGaoju Zheng
Shenzhen Second People's Hospital
Outcome results
None listed